Ireland-based Crospon has received approval from the US Food and Drug Administration for its new ES-320 dilation catheter.
The new device, which is part of EsoFLIP balloon dilation catheter line, can be used for dilation of esophageal strictures due to esophageal surgery, gastro-esophageal reflux and radiation therapy.
Crospon CEO John O’Dea said the product clearance permits the company to participate in a significantly larger market segment than that of previously announced ES-330 achalasia dilator.
"It represents our continued commitment to innovation and to expanding our product folio beyond the EndoFLIP gastrodiagnostic platform for which five US patents have issued in 2014," O’Dea added.
The company will introduce the product in October at the American College of Gastroenterology 2014 Annual Scientific Meeting in Philadelphia.
Crospon produces medical devices for monitoring, diagnosis and therapy in the areas of minimally invasive surgery and gastroenterology.